Mackenzie Financial
NVAX icon

Mackenzie Financial’s Novavax NVAX Stock Holding History

Mackenzie Financial’s Portfolio NVAX Stock Details NVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-7,482
Closed -$551K – 1518
2022
Q1 		$551K Sell
7,482
-7,026
-48% -$627K ﹤0.01% 972
2021
Q4 		$2.08M Sell
14,508
-4,124
-22% -$709K ﹤0.01% 760
2021
Q3 		$3.86M Buy
18,632
+950
+5% +$209K 0.01% 628
2021
Q2 		$3.75M Buy
17,682
+4,307
+32% +$789K 0.01% 611
2021
Q1 		$2.42M Buy
+13,375
New +$2.67M ﹤0.01% 655

Other funds holding NVAX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Coatue Management
Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Voloridge Investment Management
Voloridge Investment Management Jupiter, Florida $25B AUM 28.08% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Mackenzie Financial's NVAX Position: Q2 2022 in Review

Mackenzie Financial sold out of Novavax (NVAX) in Q2 2022, closing a stake of 7,482 shares — an estimated $551K sold.

Mackenzie Financial first reported a position in NVAX in Q1 2021 and held it in 5 quarters. The position peaked at $3.86M in Q3 2021. 325 funds tracked by Wall St. Rank hold NVAX as of Q2 2022.

  • Mackenzie Financial reported no remaining Novavax position as of Q2 2022 after selling out during the quarter.
  • Mackenzie Financial sold 7,482 Novavax shares in Q2 2022, an estimated $551K.
  • Mackenzie Financial first reported a position in Novavax in Q1 2021 and held it in 5 quarters.
  • Mackenzie Financial's Novavax position peaked at $3.86M in Q3 2021.
  • 325 funds tracked by Wall St. Rank held Novavax as of Q2 2022.

Based on Mackenzie Financial's 13F filing for Q2 2022, filed 10 Aug 2022.